Dear Editor:
COVID-19 patients and other respiratory tract infection victims are often indistinguishable, and there is the concern of asymptomatic persons capable of disease transmission [1]. In recent studies, up to 80% of patients infected with COVID-19 present with mild respiratory tract symptoms or mild pneumonia, and 1.2% of patients have no symptoms [2,3]. The screening of patients having infection risks relies mostly on emergency personnel in Taiwan. Large numbers of patient with plausible symptoms presented to the emergency department (ED) each day. The stakes of cross-infection in unidentified patients are high, especially in hospital without buffer zone for infectious diseases. As we know, unexpected community outbreak has caused in-hospital infection, infection of health care providers or temporary shutdown of emergency service in hospitals at Wakayama, Japan and Daegu, Korea.
To reduce the risk of infection in the ED and restrict the contaminated area, we implement graded waiting areas for patients with different risks of infection. Patients presented with fever or respiratory tract symptoms are classified as having high, intermediate or undetermined risks of COVID-19 infection. The principles of classification are shown in Table 1 . Three areas A, B and C were set close to the ED. Area A is located outside the hospital and had good ventilation of air. Area B and C are located in the emergency hall and have independent air conditioning system (Fig. 1 ). The seatings of all 3 areas are arranged that the distances between patients are more than 1 m. High risk patients will be guided to area A, managed and admitted as soon as possible. Intermediate risk patients have history taken and portable X-ray obtained of needed at area B. Patients with undetermined risk of infection would wait, be inspected and treated at Area C. If respiratory sampling is required, intervention will be done in the isolation room. Critically ill patients with any suspicious TOCC history or respiratory problem are resuscitated in the isolation room. Medical staffs participating in the resuscitation wear personal protective clothing and use HEPA filter for ventilation.
Table 1.
Risk of infection | Requirements |
---|---|
High | Fever or respiratory tract symptoms AND 1 of the followings in recent 14 days:
|
Intermediate | Fever or respiratory tract symptoms and any travel history to foreign countries but not highly endemic area. OR Direct contact with confirmed cases and referred for sampling. |
Undetermined | Fever or respiratory tract symptoms, but not met any of the above-mentioned criteria. |
Highly endemic areas are defined by and updated according to statement of Taiwan CDC.
With the above-mentioned measures, patients with respiratory tract infections or fever receive medical care in completely different area with other patients in the ED. After 4 weeks of prosecuting the measure of patient zoning, total of 214 patients were allocated to areas A, B and C. Of 6 patients in area A, one infected individual was found. There are 172 patients in area B and 3 were positive for COVID-19 infection. 36 patients were evaluated in area C. There is no positive result from samples acquired at area C. The positive predicted value for COVID-19 infection in 3 areas were 16.7%, 1.7% and 0%.
The graded waiting areas for patients who had different risk of COVID-19 infection facilitate management of high-risk patients and reduce the possibility of in-hospital infection.
References
- 1.Al-Tawfiq JA. Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19) Trav Med Infect Dis. 2020 Feb 27 doi: 10.1016/j.tmaid.2020.101608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145–151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Hoehl S, Berger A, Kortenbusch M, Cinatl J, Bojkova D, Rabenau H. Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China. N Engl J Med. 2020 Feb 18 doi: 10.1056/NEJMc2001899. [DOI] [PMC free article] [PubMed] [Google Scholar]